NAGEL MICHAEL purchased 2.4% of their position (1K shares) of KIROMIC BIOPHARMA, INC. on the open market
Open‑market purchase worth $3.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/12/2024ACC: 0001104659-24-070884
+1K
Net shares
Net buyer
$3.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$3.33
Trade value
$3.33K
% of position
2.4%
6/11/2024
42.30K→43.30K
Total
Net shares
+1K
Net value
$3.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | P · Purchase | +1K | $3.33 | $3.33K | 2.4% | 42.30K | 43.30K |
| Total | +1K | $3.33K | ||||||
Derivative Transactions0
No derivative transactions reported